An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer
- Walter M. Stadler
- , David J. Vaughn
- , Guru Sonpavde
- , Nicholas J. Vogelzang
- , Scott T. Tagawa
- , Daniel P. Petrylak
- , Peter Rosen
- , Chia Chi Lin
- , John Mahoney
- , Sanjiv Modi
- , Peter Lee
- , Marc S. Ernstoff
- , Wu Chou Su
- , Alexander Spira
- , Korinna Pilz
- , Richard Vinisko
- , Charles Schloss
- , Holger Fritsch
- , Charles Zhao
- , Michael A. Carducci
研究成果: Article › 同行評審
94
連結會在新分頁中打開
引文
斯高帕斯（Scopus）